Follow us on Twitter
Find us on Facebook
Stem Cell transplant trial results - The Lancet Neurology
30 Jan 2009
The Lancet Neurology has today published the results of a trial involving stem cell transplantation in people with relapsing remitting multiple sclerosis (MS).
The results of the Chicago study of around 20 people show that the treatment halted progression of disability and could potentially reverse the damage caused in MS.
Dr Doug Brown, Research Manager at the MS Society, said: “These are very encouraging results and it's exciting to see that in this trial not only is progression of disability halted, but damage appears to be reversed.
“Stem cells are showing more and more potential in the treatment of MS and the challenge we now face is proving their effectiveness in trials involving large numbers of people.”
Read more in our Research News section
Find out more about stem cells as a potential treatment for MS.
Dr Doug Brown, Research Manager at the MS Society, said: “These are very encouraging results and it's exciting to see that in this trial not only is progression of disability halted, but damage appears to be reversed.
“Stem cells are showing more and more potential in the treatment of MS and the challenge we now face is proving their effectiveness in trials involving large numbers of people.”
Read more in our Research News section
Find out more about stem cells as a potential treatment for MS.
BACK TO TOP
